Please select a Capability in order to start your service request.
Proactively protect against blood exposure
Approximately 90% of hospitalized patients require IV therapy,1 and peripheral IV catheter insertion is the most commonly performed invasive procedure in hospitals2—but it can present a significant amount of blood. Though devices and practices promoting needlestick safety can help prevent exposure to blood, clinicians should be aware of other ways to protect themselves from the risks. BD provides information that can help provide this protection.
Watch the following stories from healthcare personnel who have been exposed to blood while inserting IVs:
Registered nurse Cheryll Collins shares how her life changed after being exposed to HIV-infected blood while performing a peripheral IV catheter insertion. She also explains how she approaches IV insertion differently now and what clinicians can do to better protect themselves from contaminated blood.
Edie, an emergency/trauma nurse, shares how her friend and coworker was infected with HIV after being exposed to just a few drops of blood. She was a nurse for 25 years—adamant about using universal precautions—but one split-second decision changed her career, and her life. Edie shares her story in hopes to prevent this from happening to other nurses.
According to the Occupational Safety & Health Administration (OSHA) Enforcement Procedures for the Occupational Exposure to Bloodborne Pathogens, "The employer must use engineering and work practice controls that eliminate occupational exposure or reduce it to the lowest feasible extent."3
Review the following articles and published research on blood exposure:
A 2011 study published in Nursing shows that the rate of at-risk blood exposure for IV catheter insertions is 128 per 100,000 insertions (the combined rate of blood contact to the eyes, nose, mouth and nonintact skin).4
Nearly all of the safety professionals in a survey said that workers in their organization had, at some point, failed to wear the necessary safety equipment while on the job.5
The 2011 EPINet report "Blood and body fluid exposures" includes the following statistics:
The Centers for Disease Control and Prevention (CDC) reports the following statistics related to HIV and Hepatitis C virus (HCV):
BD has developed innovative technologies that specifically address safety and blood containment in IV catheter settings. Our product portfolio includes peripheral IV catheters designed to protect clinicians as well as patients.
This portfolio includes the following products:
The BD Nexiva closed IV catheter system is an all-in-one closed system IV catheter designed to last throughout the treatment process.
The BD Nexiva Diffusics closed IV catheter system is designed to address common CT IV challenges.
The BD Insyte Autoguard BC shielded IV catheter with blood control technology promotes safety and performance by reducing the risk of blood exposure and providing other benefits.
"Blood control and blood-contained safety peripheral intravenous cannulas (SPICVs) do not require clinicians to occlude the vessel during insertion. Ultimately, they reduce cleanup costs, nursing time and any additional costs should an exposure occur."11
* Compared to an open system
† Compared to a non-blood control IV catheter